FAQs
When do you review applications?
The TidalHealth Family Medicine Residency Program will begin reviewing ERAS applications after receiving accreditation, which should be on Oct. 25, 2024, or shortly thereafter. Those applicants who have expressed interest in our program and added their name to our mailing list will receive an email notifying them that we have received accreditation and that they may now apply to our program. Invitations to interview will be sent out on an ongoing basis until we have filled all our interview dates.
How many positions do you fill each year?
The program is approved by the ACGME to accept four categorical slots each year.
Do you allow moonlighting?
Yes, PGY-3 can moonlight with prior written approval from the program director.
What research opportunities are available?
We are the home of the TidalHealth Richard A. Henson Research Institute, which was endowed by the Richard A. Henson Foundation in 2017 and manages clinical and translational research trials for TidalHealth. Our residents will have access to the research institute to participate in research projects and the director of the institute, Robert L. Joyner, Jr., PhD, RRT, RRT-ACCS, FAARC, will hold didactic sessions for residents who want to learn more about conducting research.
Do you support applicants with J1 visas?
We consider applicants with J1 visas on a case-by-case basis.
